Literature DB >> 28167771

iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variations.

Erika M Kwon1, John P Connelly1, Nancy F Hansen2, Frank X Donovan3, Thomas Winkler4, Brian W Davis5, Halah Alkadi1, Settara C Chandrasekharappa3, Cynthia E Dunbar4, James C Mullikin2, Paul Liu6.   

Abstract

Genome integrity of induced pluripotent stem cells (iPSCs) has been extensively studied in recent years, but it is still unclear whether iPSCs contain more genomic variations than cultured somatic cells. One important question is the origin of genomic variations detected in iPSCs-whether iPSC reprogramming induces such variations. Here, we undertook a unique approach by deriving fibroblast subclones and clonal iPSC lines from the same fibroblast population and applied next-generation sequencing to compare genomic variations in these lines. Targeted deep sequencing of parental fibroblasts revealed that most variants detected in clonal iPSCs and fibroblast subclones were rare variants inherited from the parental fibroblasts. Only a small number of variants remained undetectable in the parental fibroblasts, which were thus likely to be de novo. Importantly, the clonal iPSCs and fibroblast subclones contained comparable numbers of de novo variants. Collectively, our data suggest that iPSC reprogramming is not mutagenic.

Keywords:  exome sequencing; fibroblasts; genomic variation; iPSCs; reprogramming

Mesh:

Year:  2017        PMID: 28167771      PMCID: PMC5338363          DOI: 10.1073/pnas.1616035114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data.

Authors:  Kai Wang; Mingyao Li; Dexter Hadley; Rui Liu; Joseph Glessner; Struan F A Grant; Hakon Hakonarson; Maja Bucan
Journal:  Genome Res       Date:  2007-10-05       Impact factor: 9.043

2.  Copy number variation and selection during reprogramming to pluripotency.

Authors:  Samer M Hussein; Nizar N Batada; Sanna Vuoristo; Reagan W Ching; Reija Autio; Elisa Närvä; Siemon Ng; Michel Sourour; Riikka Hämäläinen; Cia Olsson; Karolina Lundin; Milla Mikkola; Ras Trokovic; Michael Peitz; Oliver Brüstle; David P Bazett-Jones; Kari Alitalo; Riitta Lahesmaa; Andras Nagy; Timo Otonkoski
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

3.  Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression.

Authors:  Linzhao Cheng; Nancy F Hansen; Ling Zhao; Yutao Du; Chunlin Zou; Frank X Donovan; Bin-Kuan Chou; Guangyu Zhou; Shijie Li; Sarah N Dowey; Zhaohui Ye; Settara C Chandrasekharappa; Huanming Yang; James C Mullikin; P Paul Liu
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

4.  Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.

Authors:  Aaron R Quinlan; Michael J Boland; Mitchell L Leibowitz; Svetlana Shumilina; Sidney M Pehrson; Kristin K Baldwin; Ira M Hall
Journal:  Cell Stem Cell       Date:  2011-10-04       Impact factor: 24.633

5.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

6.  Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells.

Authors:  Margaret A Young; David E Larson; Chiao-Wang Sun; Daniel R George; Li Ding; Christopher A Miller; Ling Lin; Kevin M Pawlik; Ken Chen; Xian Fan; Heather Schmidt; Joelle Kalicki-Veizer; Lisa L Cook; Gary W Swift; Ryan T Demeter; Michael C Wendl; Mark S Sands; Elaine R Mardis; Richard K Wilson; Tim M Townes; Timothy J Ley
Journal:  Cell Stem Cell       Date:  2012-04-26       Impact factor: 24.633

7.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

8.  Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.

Authors:  Xiangjin Kang; Qian Yu; Yuling Huang; Bing Song; Yaoyong Chen; Xingcheng Gao; Wenyin He; Xiaofang Sun; Yong Fan
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 9.  Somatic mosaicism in the human genome.

Authors:  Donald Freed; Eric L Stevens; Jonathan Pevsner
Journal:  Genes (Basel)       Date:  2014-12-11       Impact factor: 4.096

10.  Induced pluripotent stem cell generation-associated point mutations arise during the initial stages of the conversion of these cells.

Authors:  Mayumi Sugiura; Yasuji Kasama; Ryoko Araki; Yuko Hoki; Misato Sunayama; Masahiro Uda; Miki Nakamura; Shunsuke Ando; Masumi Abe
Journal:  Stem Cell Reports       Date:  2014-01-02       Impact factor: 7.765

View more
  28 in total

Review 1.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

Review 2.  Stem cell transplantation for treating liver diseases: progress and remaining challenges.

Authors:  Shanshan Li; Yanzhen Bi; Zhongping Duan; Yongkai Chang; Feng Hong; Yu Chen
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 3.  Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications.

Authors:  Clara Steichen; Zara Hannoun; Eléanor Luce; Thierry Hauet; Anne Dubart-Kupperschmitt
Journal:  World J Stem Cells       Date:  2019-10-26       Impact factor: 5.326

Review 4.  Ocular stem cells: a narrative review of current clinical trials.

Authors:  Konstadinos Sotiropulos; Dimitrios Kourkoutas; Diamantis Almaliotis; Katherine Ploumidou; Vasileios Karampatakis
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

Review 5.  'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologies.

Authors:  Dina Simkin; Christina Ambrosi; Kelly A Marshall; Luis A Williams; Jordyn Eisenberg; Mennat Gharib; Graham T Dempsey; Alfred L George; Owen B McManus; Evangelos Kiskinis
Journal:  Trends Pharmacol Sci       Date:  2022-05       Impact factor: 17.638

6.  Insights into the Mutational Burden of Human Induced Pluripotent Stem Cells from an Integrative Multi-Omics Approach.

Authors:  Matteo D'Antonio; Paola Benaglio; David Jakubosky; William W Greenwald; Hiroko Matsui; Margaret K R Donovan; He Li; Erin N Smith; Agnieszka D'Antonio-Chronowska; Kelly A Frazer
Journal:  Cell Rep       Date:  2018-07-24       Impact factor: 9.423

7.  Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs.

Authors:  Ruchi Sharma; Vladimir Khristov; Aaron Rising; Balendu Shekhar Jha; Roba Dejene; Nathan Hotaling; Yichao Li; Jonathan Stoddard; Casey Stankewicz; Qin Wan; Connie Zhang; Mercedes Maria Campos; Kiyoharu J Miyagishima; David McGaughey; Rafael Villasmil; Mary Mattapallil; Boris Stanzel; Haohua Qian; Wai Wong; Lucas Chase; Steve Charles; Trevor McGill; Sheldon Miller; Arvydas Maminishkis; Juan Amaral; Kapil Bharti
Journal:  Sci Transl Med       Date:  2019-01-16       Impact factor: 17.956

8.  Reprogramming enriches for somatic cell clones with small-scale mutations in cancer-associated genes.

Authors:  Maike Kosanke; Katarzyna Osetek; Alexandra Haase; Lutz Wiehlmann; Colin Davenport; Adrian Schwarzer; Felix Adams; Marc-Jens Kleppa; Axel Schambach; Sylvia Merkert; Stephanie Wunderlich; Sandra Menke; Marie Dorda; Ulrich Martin
Journal:  Mol Ther       Date:  2021-04-06       Impact factor: 12.910

Review 9.  Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine.

Authors:  Mareike S Poetsch; Anna Strano; Kaomei Guan
Journal:  Stem Cells       Date:  2022-06-22       Impact factor: 5.845

10.  iPSCs are safe!

Authors:  Hualong Yan; Yun-Bo Shi; Jing Huang
Journal:  Cell Biosci       Date:  2017-05-30       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.